These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 9579226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR, Andrew R, MacLeod KM, Padfield PL.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM, Toogood AA, Tomlinson JW.
    Horm Res; 2001 Aug; 56 Suppl 1():1-6. PubMed ID: 11786677
    [Abstract] [Full Text] [Related]

  • 6. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.
    Toogood AA, Taylor NF, Shalet SM, Monson JP.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1727-30. PubMed ID: 10770221
    [Abstract] [Full Text] [Related]

  • 9. Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects.
    Weaver JU, Taylor NF, Monson JP, Wood PJ, Kelly WF.
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):13-20. PubMed ID: 9797842
    [Abstract] [Full Text] [Related]

  • 10. Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly.
    Trainer PJ, Drake WM, Perry LA, Taylor NF, Besser GM, Monson JP.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2989-92. PubMed ID: 11443156
    [Abstract] [Full Text] [Related]

  • 11. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
    Agha A, Behan LA, Forde H, Taylor NF, Smith D, Thompson CJ, Drake WM, Monson JP.
    Endocr Pract; 2018 Oct 02; 24(10):875-881. PubMed ID: 29975580
    [Abstract] [Full Text] [Related]

  • 12. Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone.
    Espiard S, McQueen J, Sherlock M, Ragnarsson O, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Skrtic S, Wahlberg J, Stewart PM, Johannsson G.
    J Clin Endocrinol Metab; 2021 Mar 08; 106(3):814-825. PubMed ID: 33236103
    [Abstract] [Full Text] [Related]

  • 13. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
    Moore JS, Monson JP, Kaltsas G, Putignano P, Wood PJ, Sheppard MC, Besser GM, Taylor NF, Stewart PM.
    J Clin Endocrinol Metab; 1999 Nov 08; 84(11):4172-7. PubMed ID: 10566668
    [Abstract] [Full Text] [Related]

  • 14. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
    Finken MJ, Andrews RC, Andrew R, Walker BR.
    J Clin Endocrinol Metab; 1999 Sep 08; 84(9):3316-21. PubMed ID: 10487705
    [Abstract] [Full Text] [Related]

  • 15. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Sep 08; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 16. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
    Best R, Walker BR.
    Clin Endocrinol (Oxf); 1997 Aug 08; 47(2):231-6. PubMed ID: 9302399
    [Abstract] [Full Text] [Related]

  • 17. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
    Kerstens MN, Buter H, Navis GJ, Dullaart RP.
    Eur J Clin Invest; 2002 Jul 08; 32(7):513-8. PubMed ID: 12153552
    [Abstract] [Full Text] [Related]

  • 18. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2003 May 08; 58(5):601-11. PubMed ID: 12699442
    [Abstract] [Full Text] [Related]

  • 19. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.
    Sigurjonsdottir HA, Andrew R, Stimson RH, Johannsson G, Walker BR.
    Eur J Endocrinol; 2009 Sep 08; 161(3):375-80. PubMed ID: 19549748
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
    Rodríguez-Arnao J, Perry L, Besser GM, Ross RJ.
    Clin Endocrinol (Oxf); 1996 Jul 08; 45(1):33-7. PubMed ID: 8796136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.